zami 1305 has been researched along with Precancerous Conditions in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braga, G; Dimito, E; Mazzocchi, C; Presta, M; Ragnotti, G; Zavanella, T; Ziliani, S | 1 |
| Braga, M; Pacces, N; Presta, M; Ragnotti, G; Zavanella, T | 1 |
2 other study(ies) available for zami 1305 and Precancerous Conditions
| Article | Year |
|---|---|
Tumor-initiating activity of the beta-blocker ZAMI 1305 in the liver of the female Wistar rat.
Topics: 2-Acetylaminofluorene; Adrenergic beta-Antagonists; Animals; DNA; Female; Hepatectomy; Liver; Liver Neoplasms, Experimental; Organ Size; Precancerous Conditions; Propanolamines; Rats; Rats, Inbred Strains | 1984 |
Further studies on the tumor-initiating activity of the beta-blocker DL-ZAMI 1305.
Topics: Adrenergic beta-Antagonists; Animals; Cell Transformation, Neoplastic; DNA; Female; gamma-Glutamyltransferase; Liver; Liver Regeneration; Precancerous Conditions; Propanolamines; Rats; Rats, Inbred Strains | 1986 |